Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases
申请人:BOEHRINGER INGELHEIM ITALIA S.p.A.
公开号:EP0523013A2
公开(公告)日:1993-01-13
New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives and physiologically acceptable acid addition salts and solvates thereof in the treatment of organic mental diseases, as for example dementia and amnestic syndromes. Pharmaceutical compositions containing them are also described.
苯并咪唑啉-2-氧代-1-羧酸衍生物及其生理上可接受的酸加成盐和溶解物在治疗有机精神疾病(如痴呆症和失忆综合症)方面的新用途。此外,还描述了含有它们的药物组合物。